Usefulness of longitudinal measurements of β-Amyloid1-42 in cerebrospinal fluid of patients with various cognitive and neurologic disorders

被引：16

作者：

Bouwman, Femke H.

van der Flier, Wiesje M.

Schoonenboom, Niki S. M.

van Elk, Evert J.

Kok, Astrid

Scheltens, Philip

Blankenstein, Marinus A.

机构：

[1] VU Univ, Med Ctr, Alzheimer Ctr, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands

[2] VU Univ, Med Ctr, Dept Neurol, NL-1081 HV Amsterdam, Netherlands

来源：

CLINICAL CHEMISTRY | 2006年 / 52卷 / 08期

关键词：

D O I：

10.1373/clinchem.2006.070193

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：1604 / 1606

页数：3

共 13 条

[1] Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment [J].

Andreasen, N ;

Minthon, L ;

Vanmechelen, E ;

Vanderstichele, H ;

Davidsson, P ;

Winblad, B ;

Blennow, K .

NEUROSCIENCE LETTERS, 1999, 273 (01) :5-8

[2] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease [J].

Andreasen, N ;

Hesse, C ;

Davidsson, P ;

Minthon, L ;

Wallin, A ;

Winblad, B ;

Vanderstichele, H ;

Vanmechelen, E ;

Blennow, K .

ARCHIVES OF NEUROLOGY, 1999, 56 (06) :673-680

[3] Cerebrospinal fluid amyloid β peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment:: Indication of carrier-mediated epitope masking of amyloid β peptides [J].

Bibl, M ;

Esselmann, H ;

Otto, M ;

Lewczuk, P ;

Cepek, L ;

Rüther, E ;

Kornhuber, J ;

Wiltfang, J .

ELECTROPHORESIS, 2004, 25 (17) :2912-2918

[4] CSF markers for incipient Alzheimer's disease [J].

Blennow, K ;

Hampel, H .

LANCET NEUROLOGY, 2003, 2 (10) :605-613

[5] Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment [J].

de Leon, MJ ;

Segal, S ;

Tarshish, CY ;

DeSanti, S ;

Zinkowski, R ;

Mehta, PD ;

Convit, A ;

Caraos, C ;

Rusinek, H ;

Tsui, W ;

Saint Louis, LA ;

DeBernardis, J ;

Kerkman, D ;

Qadri, F ;

Gary, A ;

Lesbre, P ;

Wisniewski, T ;

Poirier, J ;

Davies, P .

NEUROSCIENCE LETTERS, 2002, 333 (03) :183-186

[6] Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease:: A study in Japan [J].

Kanai, M ;

Matsubara, E ;

Isoe, K ;

Urakami, K ;

Nakashima, K ;

Arai, H ;

Sasaki, H ;

Abe, K ;

Iwatsubo, T ;

Kosaka, T ;

Watanabe, M ;

Tomidokoro, Y ;

Shizuka, M ;

Mizushima, K ;

Nakamura, T ;

Igeta, Y ;

Ikeda, Y ;

Amari, M ;

Kawarabayashi, T ;

Ishiguro, K ;

Harigaya, Y ;

Wakabayashi, K ;

Okamoto, K ;

Hirai, S ;

Shoji, M .

ANNALS OF NEUROLOGY, 1998, 44 (01) :17-26

[7] Follow-up investigations in cerebrospinal fluid of patients with dementia with Lewy bodies and Alzheimer's disease [J].

Mollenhauer, B ;

Bibl, M ;

Trenkwalder, C ;

Stiens, G ;

Cepek, L ;

Steinacker, P ;

Ciesielczyk, B ;

Neubert, K ;

Wiltfang, J ;

Kretzschmar, HA ;

Poser, S ;

Otto, M .

JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (07) :933-948

[8]

Pitman EJG, 1939, BIOMETRIKA, V31, P9, DOI 10.1093/biomet/31.1-2.9

[9] Effects of processing and storage conditions on amyloid β (1-42) and tau concentrations in cerebrospinal fluid:: Implications for use in clinical practice [J].

Schoonenboom, NSM ;

Mulder, C ;

Vanderstichele, H ;

Van Elk, EJ ;

Kok, A ;

Van Kamp, GJ ;

Scheltens, P ;

Blankenstein, MA .

CLINICAL CHEMISTRY, 2005, 51 (01) :189-195

[10] Amyloid β(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease [J].

Schoonenboom, NSM ;

Pijnenburg, YAL ;

Mulder, C ;

Rosso, SM ;

Van Elk, EJ ;

Van Kamp, GJ ;

Van Swieten, JC ;

Scheltens, P .

NEUROLOGY, 2004, 62 (09) :1580-1584

← 1 2 →